Abstract:Background: The seeds of Euphorbia lathyris are used in traditional Chinese medicines for the treatment of various medical conditions. E. lathyris contains many natural diterpenes with a lathyrane skeleton. Purpose and study design: Five lathyrane-type diterpenoids named Euphorbia factors L1, L2, L3, L8, and L9 (1-5), were investigated for cytotoxicity against A549, MDA-MB-231, KB, and MCF-7 cancer cell lines and the KB-VIN multidrug resistant (MDR) cancer cell line. Also, a tetraol derivative (6) of Euphorbia factor L2 (2) was synthesized to assess the effect of hydroxy moieties. Methods: An ethanolic extract of seeds of Euphorbia lathyris was prepared and separated into petroleum ether, EtOAc, n-butanol, and n-hexane extracts. The natural diterpenes were isolated by using silica gel and Sephadex LH-20 column chromatography as well as preparative thin-layer chromatography. Saponification of 2 gave tetraol derivative 6. Cytotoxic activity was determined by the sulforhodamine B (SRB) colorimetric assay. Mechanism of action studies focused on the impact of compounds on the cell cycle progression as well as cell morphology. Results: Compound 5 exhibited the strongest cytotoxicity against all cell lines, while compound 2 showed selectivity against KB-VIN. In cells treated with 3 and 5, accumulation of G1 to early S phase cells was obvious, while no effect was seen on G2/M phase. Conclusion: Analysis of the screening data compared with compound structures suggested that the substitutions at C-3, C-5, C-7, and C-15 are critical for cytotoxicity, as well as cell type-selectivity. Furthermore, results of cytotoxic mechanism analysis demonstrated for the first time that compounds 3 and 5 disrupted normal cell cycle progression, whereas compounds 2‒5 induced obvious actin filament aggregation, as well as partial interference of the microtubule network.

Cardiac glycosides with cytotoxic activity from the seeds of Thevetia peruviana

Thevetia thevetioides Cardenolide and Related Cardiac Glycoside Profile in Mature and Immature Seeds by High-Resolution Thin-Layer Chromatography (HPTLC) and Quadrupole Time of Flight–Tandem Mass Spectrometry (Q-TOF MS/MS) Reveals Insights of the Cardenolide Biosynthetic Pathway

Cytotoxic cardenolides from Calotropis gigantea

Cardiac glycosides from Digitalis lanata and their cytotoxic activities

A new cardenolide glycoside from the roots of Streptocaulon juventas (lour.) merr. (Asclepiadaceae)

Cytotoxic And Apoptosis-Inducing Activity Of Triterpene Glycosides From Holothuria Scabra And Cucumaria Frondosa Against Hepg2 Cells

Cardenolides from the Bark of Calotropis Gigantea.

Two cardenolide glycosides from the seed fairs of Asclepias curassavica and their cytotoxic activities

A new periplogenin cardenolide from the seeds of Antiaris toxicaria

Cytotoxic Cardenolides from the Root Bark of Calotropis Gigantea

Calosides A-F, Cardenolides from Calotropis gigantea and Their Cytotoxic Activity

Triterpene saponins from the seeds of Erythrophleum fordii and their cytotoxic activities

Cardenolides from Saussurea Stella with Cytotoxicity Toward Cancer Cells

Tirucallane-type Triterpenoids from the Fruits of Phellodendron Chinense Schneid and Their Cytotoxic Activities.

Cytotoxic cardiac glycosides from the root of Streblus asper

Ten new glycosides, carissaedulosides A–J from the root barks of Carissa edulis and their cytotoxicities

Mechanism of action of cytotoxic compounds from the seeds of Euphorbia lathyris

Diverse terpenoid glycosides with in vitro cytotoxicity from Glechoma longituba

A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways

A new cytotoxic cardenolide from the roots of Calotropis gigantea

Non-classical cardenolides from Calotropis gigantea exhibit anticancer effect as HIF-1 inhibitors